Ophthalmology Flashcards

1
Q

What is the most common cause of blindness in adults aged 35-65 years-old?

A

Diabetic retinopathy

This condition is prevalent among adults in this age range.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What causes increased retinal blood flow and abnormal metabolism in the retinal vessel walls in diabetic retinopathy?

A

Hyperglycaemia

This condition leads to damage to endothelial cells and pericytes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the consequence of endothelial dysfunction in diabetic retinopathy?

A

Increased vascular permeability

This causes characteristic exudates seen on fundoscopy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What predisposes to the formation of microaneurysms in diabetic retinopathy?

A

Pericyte dysfunction

This is a critical factor in the disease’s progression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is neovascularization in diabetic retinopathy thought to be caused by?

A

Production of growth factors in response to retinal ischaemia

This is a key feature in the progression of the disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the three classifications of diabetic retinopathy?

A

Non-proliferative diabetic retinopathy (NPDR), proliferative retinopathy (PDR), maculopathy

These classifications help in understanding the severity and management of the condition.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What characterizes mild non-proliferative diabetic retinopathy (NPDR)?

A

1 or more microaneurysm

This is the least severe form of NPDR.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the features of moderate non-proliferative diabetic retinopathy (NPDR)?

A

Microaneurysms, blot haemorrhages, hard exudates, cotton wool spots, venous beading/looping, IRMA

These features indicate a progression in severity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What defines severe non-proliferative diabetic retinopathy (NPDR)?

A

Blot haemorrhages and microaneurysms in 4 quadrants, venous beading in at least 2 quadrants, IRMA in at least 1 quadrant

This is a critical stage requiring close monitoring.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is a key feature of proliferative diabetic retinopathy (PDR)?

A

Retinal neovascularisation

This may lead to vitreous haemorrhage and is more common in Type I DM.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the key features of maculopathy?

A

Location-based severity, hard exudates, changes on macula, check visual acuity

This condition can be serious regardless of severity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What should be optimized in all patients with diabetic retinopathy?

A

Glycaemic control, blood pressure, and hyperlipidemia

These are crucial for managing the condition.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the management for maculopathy if there is a change in visual acuity?

A

Intravitreal vascular endothelial growth factor (VEGF) inhibitors

This treatment is essential to preserve vision.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the management approach for severe/very severe non-proliferative retinopathy?

A

Consider panretinal laser photocoagulation

This is a critical intervention to prevent progression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the primary treatment for proliferative retinopathy?

A

Panretinal laser photocoagulation

This treatment is aimed at reducing complications.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What percentage of patients develop a noticeable reduction in their visual fields after treatment for proliferative retinopathy?

A

Around 50%

This is due to scarring of peripheral retinal tissue.

17
Q

What other complications can arise from treatment of proliferative retinopathy?

A

Decrease in night vision, generalised decrease in visual acuity, macular oedema

These complications can significantly affect quality of life.

18
Q

What examples of intravitreal VEGF inhibitors are mentioned?

A

Ranibizumab

This is often used in combination with other treatments.

19
Q

What is indicated if there is severe or vitreous haemorrhage in proliferative retinopathy?

A

Vitreoretinal surgery

This is a last-resort option for serious cases.